GIFT

CardCash.com Introduces Discounted Gift Card Solutions for Rising Costs of GLP-1 Medications

CardCash.com offers discounted gift cards for GLP-1 medications, helping consumers save on rising prescription costs.

Quiver AI Summary

Giftify, Inc., through its platform CardCash.com, is introducing cost-effective solutions to help consumers manage the rising expenses of popular GLP-1 weight loss medications like Ozempic and Zepbound. By utilizing discounted pharmacy gift cards available from major retailers such as CVS and Walgreens, CardCash.com aims to alleviate the financial burden of these medications, contributing to the national conversation on healthcare affordability. Users can combine these discounted gift cards with manufacturer savings programs and prescription discount services for further savings. The initiative reflects Giftify's strategy to expand into healthcare savings while addressing the increasing demand for medications like Ozempic and Mounjaro.

Potential Positives

  • CardCash.com is addressing a significant market need by offering cost-effective solutions for high-demand GLP-1 medications, which aligns with national efforts to improve healthcare affordability.
  • The initiative allows consumers to combine discounted pharmacy gift cards with other savings programs, enhancing the value proposition for both the company and its customers.
  • This move expands Giftify’s strategic focus into a high-growth consumer market, demonstrating the versatility of its business model in the healthcare sector.

Potential Negatives

  • The press release presents a new initiative that may signal the company's need to diversify away from its core business, suggesting potential underlying weaknesses in its current market offerings.
  • Describing consumer feedback in terms of significant savings relies on anecdotal evidence, which may challenge the credibility of the initiative and raise questions about its overall effectiveness.
  • The forward-looking statements highlight risks and uncertainties, indicating that the company is aware of potential challenges that could affect future performance and undermine investor confidence.

FAQ

What are GLP-1 medications and why are they in demand?

GLP-1 medications are prescription drugs like Ozempic and Zepbound, increasingly sought for weight loss and diabetes management.

How can CardCash.com help reduce prescription costs?

CardCash.com offers discounted pharmacy gift cards that can be used to purchase high-cost GLP-1 medications, lowering out-of-pocket expenses.

Which pharmacies are involved in the CardCash.com program?

CardCash.com partners with major retailers like CVS and Walgreens to offer discounted gift cards for medication purchases.

Can I combine CardCash savings with other discount programs?

Yes, users can combine CardCash's discounted gift cards with manufacturer savings programs and services like GoodRx and SingleCare.

What is Giftify, Inc.'s role in this initiative?

Giftify, Inc. operates CardCash.com and aims to create cost-saving solutions in the healthcare sector through its gift card marketplace.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


$GIFT Insider Trading Activity

$GIFT insiders have traded $GIFT stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $GIFT stock by insiders over the last 6 months:

  • STEVE HANDY (CFO) has made 3 purchases buying 25,620 shares for an estimated $654,653,250 and 0 sales.
  • BALAZS WELLISCH (CTO) has made 2 purchases buying 36,000 shares for an estimated $53,700 and 0 sales.
  • KETAN THAKKER (CEO) has made 2 purchases buying 12,350 shares for an estimated $17,109 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Full Release




CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows



SCHAUMBURG, IL, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ:GIFT) (the "Company"), the owner and operator of CardCash.com and Restaurant.com, and a leader in the incentives and rewards industry, today announced that CardCash.com is offering consumers smart saving solutions for high-cost GLP-1 weight loss prescription medications like Ozempic (semaglutide) from Novo Nordisk and Zepbound (tirzepatide) from Eli Lilly.



CardCash.com, Giftify's secondary gift card exchange platform, provides consumers with an innovative approach to reduce rising out-of-pocket expenses for increasingly popular GLP-1 medications. The strategy leverages discounted pharmacy gift cards from major retailers including CVS and Walgreens.



This program aligns with current national efforts to address healthcare affordability challenges. By providing practical tools to reduce prescription costs, CardCash.com is contributing to the ongoing public dialogue around making essential medications more accessible for all Americans, particularly as policymakers continue to explore comprehensive solutions to rising healthcare expenses.



Consumer feedback validates the financial impact of this approach. “As one Trustpilot reviewer, Corey Polk, shared, ‘I had significant savings on my Walgreens cards. I used it to buy Ozempic, and now I save about $30 a month.’ This is exactly what we aim for at CardCash — helping consumers find financial relief where they need it most,” said Carol Rosenblum, Marketing Manager at CardCash.com.



The platform's strategy creates a multi-layered savings opportunity for medication purchasers. Users can combine CardCash's discounted gift cards with manufacturer savings programs and prescription discount services like GoodRx and SingleCare. Additional cost reductions can be achieved through price comparisons between major pharmacy retailers including CVS, Walgreens, and Walmart.



This healthcare cost reduction initiative addresses growing market demand for GLP-1 medications such as Ozempic, Mounjaro, and Wegovy. By providing access to discounted gift cards that can be applied toward pharmaceutical purchases, CardCash extends Giftify's value proposition into the healthcare sector.



"As prescription medication costs continue to rise, we're leveraging our established gift card marketplace to create meaningful savings opportunities in healthcare," said Ketan Thakker, CEO of Giftify, Inc. "This initiative aligns perfectly with our strategic focus on expanding our digital savings platforms into high-growth consumer markets. The increasing adoption of GLP-1 medications represents a significant opportunity to demonstrate the versatility and value of our business model."




About Giftify, Inc.



Giftify, Inc. is a pioneer in the incentive and rewards industry with a focus on retail, dining & entertainment experiences, as the owner and operator of leading digital platforms, CardCash.com and Restaurant.com. CardCash.com is a leading secondary gift card exchange platform, allowing consumers and retailers to realize value by buying and selling gift cards at various scales. Its Restaurant.com is the nation’s largest restaurant-focused digital deals brand. Restaurant.com and our Corporate Incentives division connect digital consumers, businesses and communities offering thousands of dining, retail and entertainment deals options nationwide at over 184,000 restaurants and retailers. Restaurant.com prides itself on offering the best deal, every meal. Our gift cards and restaurant certificates allow customers to save at thousands of restaurants across the country with just a few clicks.



For more information, visit:


www.giftifyinc.com


and


www.cardcash.com


and


https://www.restaurant.com


.




Forward-Looking Statements



Press Releases may include forward-looking statements. In particular, the words “believe,” “may,” “could,” “should,” “expect,” “anticipate,” “estimate,” “project," "propose," "plan," "intend," and similar conditional words and expressions are intended to identify forward-looking statements. Any statements made in this news release about an action, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the company. Accordingly, you should not place undue reliance on these forward-looking statements. Although the company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The company takes no obligation to update or correct its own forward-looking statements, except as required by law or those prepared by third parties that are not paid by the company. Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Giftify, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Giftify, Inc. is unable to give any assurance that its expectations will be attained. Factors that could cause actual results to differ materially from expectations include the company’s ability identify a suitable business model for the corporation.




Investors Contacts:





IR@giftifyinc.com







This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.